Skip to content

8.4% Sodium Bicarbonate Locks in Intestinal Failure

Sodium Bicarb Locks in Intestinal Failure

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05813535
Enrollment
6
Registered
2023-04-14
Start date
2022-12-01
Completion date
2025-03-01
Last updated
2026-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CRBSI - Catheter Related Bloodstream Infection, Intestinal Failure

Brief summary

We plan to include children with intestinal failure, a condition where the gut is not functioning properly, leading these children to need central venous catheters (line that goes through the skin into the blood stream) for nutritional support and hydration. Such patients have a very high risk for catheter infection. The study will include placing an agent (sodium bicarbonate) into the central catheter when the catheter is not in use. This is referred to as a lock. The lock would be used daily and removed when patients start their nutritional support and hydration through the catheter.

Detailed description

Children with intestinal failure who rely on a silicone based central venous catheter for parenteral nutrition to provide nutritional support and hydration will be invited to participate in this study. The intervention will offer use of a specific catheter lock solution (8.4% sodium bicarbonate) when the catheter is not in use. This includes daily lock use with removal of the lock at end of dwell time.

Interventions

DRUGSodium bicarb lock

8.4% sodium bicarb locks when off venous nutrition

Sponsors

Riad Rahhal
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Subject fulfills diagnosis of intestinal failure with a central venous catheter in place used daily on outpatient basis for intravenous nutrition and /or intravenous hydration * Subject is less than 18 years of age at the time of study entry * Subject with history of at least 1 documented catheter related blood stream infection (verified by blood culture)

Design outcomes

Primary

MeasureTime frameDescription
Rate of Catheter Related Bloodstream InfectionsThrough study completion, an average of 1 yearNumber of infections per 1000 catheter days

Countries

United States

Baseline characteristics

Characteristic
Age, Categorical
<=18 years
6 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Age, Continuous12.3 years
Catheter related blood stream infection rate3.0 infections per 1000 catheter days
Sex: Female, Male
Female
3 Participants
Sex: Female, Male
Male
3 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 60 / 6
other
Total, other adverse events
0 / 60 / 6
serious
Total, serious adverse events
0 / 60 / 6

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 29, 2026